Invasive aspergillosis, candidermia in nonneutropenic patients and the following Candida infections: disseminated infections in skin and infections in abdomen, kidney, bladder wall and wounds. Esophageal candidiasis, Serious fungal infections caused by Scedosporium apiospermum.
Tablets or oral suspension should be taken at least one hour before or one hour following, a meal Voriconazole I.V. for injection requires reconstitution to 10mg/mL and subsequent dilution to 5mg/mL or less prior to administration as an infusion, at a maximum rate of 3mg/kg per hour over 1-2 hours. Voriconazole I.V. must not be infused concomitantly with any blood product or short-term infusion of concentrated electrolytes, even if the two infusions are running in separate intravenous lines (or
Visual disturbances, fever, rash, vomiting, nausea, diarrhea, headache, sepsis, peripheral edema, abdominal pain, and respiratory disorder.
|Brand Name||Manufactured by|
|MEONAZOLE||MERIT ORGANICS LTD.|
|REXVOR||ROWAN BIOCEUTICALS (P) LTD.|
|RICOLE||BIOCARE (Div. of Health biotech Ltd.)|
|VORAGE||Sun Pharmaceutical Industries Ltd.|
|VORIFIT-200||INTAS PHARMACEUTICALS LTD.|